Generation Bio Co. financial data

Symbol
GBIO on Nasdaq
Location
301 Binney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 778 % -47.2%
Debt-to-equity 91.6 % +110%
Return On Equity -92.9 % -106%
Return On Assets -48.5 % -54.3%
Operating Margin -1.3K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 66.7M shares +1.23%
Common Stock, Shares, Outstanding 66.7M shares +1.4%
Entity Public Float 299M USD -2.16%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 66.5M shares +1.33%
Weighted Average Number of Shares Outstanding, Diluted 66.5M shares +1.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 13.2M USD +365%
Research and Development Expense 80.5M USD -7.07%
General and Administrative Expense 45M USD -10.8%
Operating Income (Loss) -171M USD -25.4%
Nonoperating Income (Expense) 12.3M USD +32.6%
Net Income (Loss) Attributable to Parent -158M USD -24.9%
Earnings Per Share, Basic -2.39 USD/shares -14.9%
Earnings Per Share, Diluted -2.39 USD/shares -14.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.5M USD -80.3%
Marketable Securities, Current 188M USD +11.4%
Accounts Receivable, after Allowance for Credit Loss, Current 1.34M USD
Other Assets, Current 290K USD +12%
Assets, Current 223M USD -30.4%
Property, Plant and Equipment, Net 17.1M USD -22.2%
Operating Lease, Right-of-Use Asset 22.1M USD -60.4%
Other Assets, Noncurrent 200K USD -39.9%
Assets 265M USD -34.5%
Accounts Payable, Current 1.91M USD -18%
Employee-related Liabilities, Current 3.88M USD -10.7%
Contract with Customer, Liability, Current 5.68M USD
Liabilities, Current 30.1M USD +13.7%
Contract with Customer, Liability, Noncurrent 55.1M USD
Operating Lease, Liability, Noncurrent 85.3M USD +17.7%
Liabilities 150M USD -0.49%
Accumulated Other Comprehensive Income (Loss), Net of Tax -280K USD -1117%
Retained Earnings (Accumulated Deficit) -666M USD -31.2%
Stockholders' Equity Attributable to Parent 115M USD -54.6%
Liabilities and Equity 265M USD -34.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.7M USD -14.5%
Net Cash Provided by (Used in) Financing Activities -125K USD -100%
Net Cash Provided by (Used in) Investing Activities -553K USD +90.2%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 66.7M shares +1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.7M USD -79.7%
Deferred Tax Assets, Valuation Allowance 176M USD +27.3%
Operating Lease, Liability 60.8M USD
Payments to Acquire Property, Plant, and Equipment 1.92M USD +154%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -159M USD -25.4%
Lessee, Operating Lease, Liability, to be Paid 137M USD +31.1%
Property, Plant and Equipment, Gross 38.2M USD -2.38%
Operating Lease, Liability, Current 8.63M USD +6.12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.6M USD +2.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.2M USD +13.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38.9M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.1M USD +2.92%
Deferred Tax Assets, Operating Loss Carryforwards 96.9M USD +8.26%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.6M USD +2.83%
Operating Lease, Payments 1.9M USD -38.7%
Additional Paid in Capital 782M USD +2.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.25M USD -2.2%
Deferred Tax Assets, Net of Valuation Allowance 198M USD +25.3%
Share-based Payment Arrangement, Expense 19.7M USD -17.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%